Novartis and Amgen form neuroscience collaboration; the FDA approves a drug for people undergoing chemotherapy; a judge considers denying Pfizer’s request to toss federal lawsuit
More than 400 drugs in development for neurological disorders
July 13, 2015
7:30 pm
PhRMA and the Epilepsy Foundation said 50-million Americans are affected by disorders such as Alzheimer’s disease and multiple sclerosis.
AI Deciphered: Discovering the Potential for Marketers and Communicators